New research has been released that further highlights the potential role of medical cannabis in combating the Nation’s opioid crisis . Two studies, published on April 2nd by the Journal of the American Medical Association reveal a net decrease in opioid prescriptions in states with medical cannabis laws for Medicare and Medicaid populations.
The first study, conducted by researchers at the University of Georgia, found that states with active medical cannabis dispensaries saw 3,742,000 fewer daily doses per year filled for prescription opioids under Medicare Part D (typically enrollees are over 65) compared to states without medical cannabis programs. This decrease equates to about a 14% reduction in opioid prescriptions in states with medical cannabis laws. The other study revealed that states with medical cannabis laws were associated with a 5.88% lower rate of opioid prescribing for individuals enrolled in Medicaid (typically enrollees are low income) than states without medical cannabis laws.
“This research continues to validate the notion that cannabis is an effective tool in pain management” said Steph Sherer, Executive Director for Americans for Safe Access. “The latest numbers show us that there were over